Clinical Trial

Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated July 18, 2024 (before its estimated April 28, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study has been designed to explore the clinical efficacy and safety of HS-10374 in the treatment of active psoriatic arthritis. Additionally, this study is to find the optimal dosing for the future clinical development of HS-10374.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-12-08.
Status change: Not Yet Recruiting → Recruiting 2024-07-17
Trial Details
NCT Number NCT06176508
Lead Sponsor Hansoh BioMedical R&D Company
Conditions Psoriatic Arthritis
Enrollment 160 participants
Start Date 2024-02-26
Primary Completion 2026-04-28 (estimated)
Study Completion 2026-08-28 (estimated)
Updated on ClinicalTrials.gov 2024-07-18